Marion Gruber, former director of the FDA’s Office of Vaccines Research and Review
FDA emails show how vaccine leader questioned 'hyper-accelerated' 2021 review of Pfizer shot
The FDA’s top vaccine official raised concerns that a sharply accelerated process to review and formally approve Pfizer’s Covid-19 vaccine would undermine public confidence in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
